Fig. 2From: Background malaria incidence and parasitemia during the three-dose RTS,S/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malariaDensity Plots of Anti-CSP Antibody Response (One Month Post-Vaccination) in the RTS,S/AS01 GroupBack to article page